| Bioactivity | Angiogenesis inhibitor 7 (compound BT2) ia a potent inhibitor of angiogenesis. Angiogenesis inhibitor 7 inhibits ERK phosphorylation, FosB/ΔFosB and VCAM-1 expression[1]. |
| CAS | 922029-50-3 |
| Formula | C18H18N2O4 |
| Molar Mass | 326.35 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. NewSouth Innovations Pty Limited. Treatment methods comprising administering inhibitors of FosB/ΔFosB expression and/or VCAM-1 expression and/or ERK1/2 phosphorylation. World Intellectual Property Organization, WO2021184059 A1 2021-09-23 |
Angiogenesis inhibitor 7
CAS: 922029-50-3 F: C18H18N2O4 W: 326.35
Angiogenesis inhibitor 7 (compound BT2) ia a potent inhibitor of angiogenesis. Angiogenesis inhibitor 7 inhibits ERK pho
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.